AXIM BIOTECHNOLOGIES, INC. Increase (Decrease) in Derivative Liabilities
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Increase (Decrease) in Derivative Liabilities of -$418.77 thousand for the 9-month period ending 2022-09-30, per its 10-Q/A filed 2022-11-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-11-15
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-09-30 was $500.89K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-06-30 was -$332.58K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-03-31 was -$587.08K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-06-30 was $0.00.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month |
|---|---|---|---|
| 2022-09-30 | $500.89K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-15 | $168.31K derived: sum of 2 quarters · filed 2022-11-15 | -$418.77K 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | -$332.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | -$919.66K 10-Q · filed 2022-08-16 | |
| 2022-03-31 | -$587.08K 10-Q · filed 2022-05-23 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | $0.00 10-Q · filed 2022-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-23 |